EverQuote, Inc. (NASDAQ: EVER) disclosed in a Form 4 filing that its Chief Accounting Officer, Ayotte Jon, sold 364 shares of Class A common stock on April 6, 2026. The shares were transacted at $15.35 apiece, generating a total sale value of $5,587. The disposition was carried out pursuant to a previously established Rule 10b5-1 trading plan adopted on August 11, 2025.
Following the sale, Ayotte directly holds 84,301 shares of EverQuote. The filing did not indicate any deviation from the terms of the trading plan.
Market context around the transaction: EverQuote's stock is trading close to its 52-week low of $13.93 and is down 43% year-to-date. Despite the decline, an InvestingPro assessment included in public information suggests the company is undervalued at current market levels. The same analysis notes that EverQuote carries more cash than debt on its balance sheet and assigns the company a "GREAT" financial health score.
The insider sale occurs against the backdrop of EverQuote's notably strong fourth-quarter 2025 financial results. The company reported earnings per share (EPS) of $1.54, substantially above the consensus estimate of $0.36. Revenue for the period came in at $195.3 million, topping expectations of $176.82 million.
Still, several equity research firms have trimmed their price targets for EverQuote following the results and accompanying guidance. Craig-Hallum lowered its target from $33 to $20, citing uncertainty around how insurance carriers are approaching the market. Needham reduced its target from $40 to $25 while retaining a Buy rating and flagging a slower outlook for the first quarter of 2026. Canaccord Genuity also cut its price target from $33 to $28, referencing the company’s below-expectations guidance for the upcoming quarter. Each of these firms, however, maintained a Buy rating on EverQuote shares.
Analyst commentary accompanying the target adjustments emphasizes an anticipated shift in insurance carriers' marketing behavior, with carriers expected to take a more measured approach to marketing spend in the first quarter of 2026. The combination of strong reported results and cautious forward guidance from the company appears to be driving the divergence between near-term sentiment and longer-term analyst convictions.
From a governance and compliance perspective, the sale being executed under a Rule 10b5-1 plan indicates this was part of a prearranged schedule rather than an ad hoc trade. The transaction size and value are modest relative to the company’s market capitalization and the insider’s remaining holdings.
Given the information disclosed, observers can note the contrast between EverQuote’s recent operating performance and the market’s more cautious pricing, as reflected in both share performance and the lowered price targets from several brokerages. The available data also highlight EverQuote’s reported balance-sheet position, which InvestingPro characterizes as cash-rich relative to debt.